Engineers at MIT, Nanyang Technological University, and several companies have developed a compact and inexpensive technology for detecting and measuring lead concentrations in water, potentially enabling a significant advance in tackling this persistent global health issue.

The World Health Organization estimates that 240 million people worldwide are exposed to drinking water that contains unsafe amounts of toxic lead, which can affect brain development in children, cause birth defects, and produce a variety of neurological, cardiac, and other damaging effects. In the United States alone, an estimated 10 million households still get drinking water delivered through lead pipes.

“It’s an unaddressed public health crisis that leads to over 1 million deaths annually,” says Jia Xu Brian Sia, an MIT postdoc and the senior author of the paper describing the new technology.

But testing for lead in water requires expensive, cumbersome equipment and typically requires days to get results. Or, it uses simple test strips that simply reveal a yes-or-no answer about the presence of lead but no information about its concentration. Current EPA regulations require drinking water to contain no more that 15 parts per billion of lead, a concentration so low it is difficult to detect.

The new system, which could be ready for commercial deployment within two or three years, could detect lead concentrations as low as 1 part per billion, with high accuracy, using a simple chip-based detector housed in a handheld device. The technology gives nearly instant quantitative measurements and requires just a droplet of water.

The findings are described in a paper appearing today in the journal Nature Communications, by Sia, MIT graduate student and lead author Luigi Ranno, Professor Juejun Hu, and 12 others at MIT and other institutions in academia and industry.

The team set out to find a simple detection method based on the use of photonic chips, which use light to perform measurements. The challenging part was finding a way to attach to the photonic chip surface certain ring-shaped molecules known as crown ethers, which can capture specific ions such as lead. After years of effort, they were able to achieve that attachment via a chemical process known as Fischer esterification. “That is one of the essential breakthroughs we have made in this technology,” Sia says.

In testing the new chip, the researchers showed that it can detect lead in water at concentrations as low as one part per billion. At much higher concentrations, which may be relevant for testing environmental contamination such as mine tailings, the accuracy is within 4 percent.

The device works in water with varying levels of acidity, ranging from pH values of 6 to 8, “which covers most environmental samples,” Sia says. They have tested the device with seawater as well as tap water, and verified the accuracy of the measurements.

In order to achieve such levels of accuracy, current testing requires a device called an inductive coupled plasma mass spectrometer. “These setups can be big and expensive,” Sia says. The sample processing can take days and requires experienced technical personnel.

While the new chip system they developed is “the core part of the innovation,” Ranno says, further work will be needed to develop this into an integrated, handheld device for practical use. “For making an actual product, you would need to package it into a usable form factor,” he explains. This would involve having a small chip-based laser coupled to the photonic chip. “It’s a matter of mechanical design, some optical design, some chemistry, and figuring out the supply chain,” he says. While that takes time, he says, the underlying concepts are straightforward.

The system can be adapted to detect other similar contaminants in water, including cadmium, copper, lithium, barium, cesium, and radium, Ranno says. The device could be used with simple cartridges that can be swapped out to detect different elements, each using slightly different crown ethers that can bind to a specific ion.

“There’s this problem that people don’t measure their water enough, especially in the developing countries,” Ranno says. “And that’s because they need to collect the water, prepare the sample, and bring it to these huge instruments that are extremely expensive.” Instead, “having this handheld device, something compact that even untrained personnel can just bring to the source for on-site monitoring, at low costs,” could make regular, ongoing widespread testing feasible.

Hu, who is the John F. Elliott Professor of Materials Science and Engineering, says, “I’m hoping this will be quickly implemented, so we can benefit human society. This is a good example of a technology coming from a lab innovation where it may actually make a very tangible impact on society, which is of course very fulfilling.”

“If this study can be extended to simultaneous detection of multiple metal elements, especially the presently concerning radioactive elements, its potential would be immense,” says Hou Wang, an associate professor of environmental science and engineering at Hunan University in China, who was not associated with this work.

Wang adds, “This research has engineered a sensor capable of instantaneously detecting lead concentration in water. This can be utilized in real-time to monitor the lead pollution concentration in wastewater discharged from industries such as battery manufacturing and lead smelting, facilitating the establishment of industrial wastewater monitoring systems. I think the innovative aspects and developmental potential of this research are quite commendable.”

Wang Qian, a principal research scientist at A*STAR’s Institute of Materials Research in Singapore, who also was not affiliated with this work, says, “The ability for the pervasive, portable, and quantitative detection of lead has proved to be challenging primarily due to cost concerns. This work demonstrates the potential to do so in a highly integrated form factor and is compatible with large-scale, low-cost manufacturing.”

The team included researchers at MIT, at Nanyang Technological University and Temasek Laboratories in Singapore, at the University of Southampton in the U.K., and at companies Fingate Technologies, in Singapore, and Vulcan Photonics, headquartered in Malaysia. The work used facilities at MIT.nano, the Harvard University Center for Nanoscale Systems, NTU’s Center for Micro- and Nano-Electronics, and the Nanyang Nanofabrication Center.

Engineers at MIT, Nanyang Technological University, and several companies have developed a compact and inexpensive technology for detecting and measuring lead concentrations in water, potentially enabling a significant advance in tackling this persistent global health issue.

The World Health Organization estimates that 240 million people worldwide are exposed to drinking water that contains unsafe amounts of toxic lead, which can affect brain development in children, cause birth defects, and produce a variety of neurological, cardiac, and other damaging effects. In the United States alone, an estimated 10 million households still get drinking water delivered through lead pipes.

“It’s an unaddressed public health crisis that leads to over 1 million deaths annually,” says Jia Xu Brian Sia, an MIT postdoc and the senior author of the paper describing the new technology.

But testing for lead in water requires expensive, cumbersome equipment and typically requires days to get results. Or, it uses simple test strips that simply reveal a yes-or-no answer about the presence of lead but no information about its concentration. Current EPA regulations require drinking water to contain no more that 15 parts per billion of lead, a concentration so low it is difficult to detect.

The new system, which could be ready for commercial deployment within two or three years, could detect lead concentrations as low as 1 part per billion, with high accuracy, using a simple chip-based detector housed in a handheld device. The technology gives nearly instant quantitative measurements and requires just a droplet of water.

The findings are described in a paper appearing today in the journal Nature Communications, by Sia, MIT graduate student and lead author Luigi Ranno, Professor Juejun Hu, and 12 others at MIT and other institutions in academia and industry.

The team set out to find a simple detection method based on the use of photonic chips, which use light to perform measurements. The challenging part was finding a way to attach to the photonic chip surface certain ring-shaped molecules known as crown ethers, which can capture specific ions such as lead. After years of effort, they were able to achieve that attachment via a chemical process known as Fischer esterification. “That is one of the essential breakthroughs we have made in this technology,” Sia says.

In testing the new chip, the researchers showed that it can detect lead in water at concentrations as low as one part per billion. At much higher concentrations, which may be relevant for testing environmental contamination such as mine tailings, the accuracy is within 4 percent.

The device works in water with varying levels of acidity, ranging from pH values of 6 to 8, “which covers most environmental samples,” Sia says. They have tested the device with seawater as well as tap water, and verified the accuracy of the measurements.

In order to achieve such levels of accuracy, current testing requires a device called an inductive coupled plasma mass spectrometer. “These setups can be big and expensive,” Sia says. The sample processing can take days and requires experienced technical personnel.

While the new chip system they developed is “the core part of the innovation,” Ranno says, further work will be needed to develop this into an integrated, handheld device for practical use. “For making an actual product, you would need to package it into a usable form factor,” he explains. This would involve having a small chip-based laser coupled to the photonic chip. “It’s a matter of mechanical design, some optical design, some chemistry, and figuring out the supply chain,” he says. While that takes time, he says, the underlying concepts are straightforward.

The system can be adapted to detect other similar contaminants in water, including cadmium, copper, lithium, barium, cesium, and radium, Ranno says. The device could be used with simple cartridges that can be swapped out to detect different elements, each using slightly different crown ethers that can bind to a specific ion.

“There’s this problem that people don’t measure their water enough, especially in the developing countries,” Ranno says. “And that’s because they need to collect the water, prepare the sample, and bring it to these huge instruments that are extremely expensive.” Instead, “having this handheld device, something compact that even untrained personnel can just bring to the source for on-site monitoring, at low costs,” could make regular, ongoing widespread testing feasible.

Hu, who is the John F. Elliott Professor of Materials Science and Engineering, says, “I’m hoping this will be quickly implemented, so we can benefit human society. This is a good example of a technology coming from a lab innovation where it may actually make a very tangible impact on society, which is of course very fulfilling.”

“If this study can be extended to simultaneous detection of multiple metal elements, especially the presently concerning radioactive elements, its potential would be immense,” says Hou Wang, an associate professor of environmental science and engineering at Hunan University in China, who was not associated with this work.

Wang adds, “This research has engineered a sensor capable of instantaneously detecting lead concentration in water. This can be utilized in real-time to monitor the lead pollution concentration in wastewater discharged from industries such as battery manufacturing and lead smelting, facilitating the establishment of industrial wastewater monitoring systems. I think the innovative aspects and developmental potential of this research are quite commendable.”

Wang Qian, a principal research scientist at A*STAR’s Institute of Materials Research in Singapore, who also was not affiliated with this work, says, “The ability for the pervasive, portable, and quantitative detection of lead has proved to be challenging primarily due to cost concerns. This work demonstrates the potential to do so in a highly integrated form factor and is compatible with large-scale, low-cost manufacturing.”

The team included researchers at MIT, at Nanyang Technological University and Temasek Laboratories in Singapore, at the University of Southampton in the U.K., and at companies Fingate Technologies, in Singapore, and Vulcan Photonics, headquartered in Malaysia. The work used facilities at MIT.nano, the Harvard University Center for Nanoscale Systems, NTU’s Center for Micro- and Nano-Electronics, and the Nanyang Nanofabrication Center.

Engineers at MIT, Nanyang Technological University, and several companies have developed a compact and inexpensive technology for detecting and measuring lead concentrations in water, potentially enabling a significant advance in tackling this persistent global health issue.

The World Health Organization estimates that 240 million people worldwide are exposed to drinking water that contains unsafe amounts of toxic lead, which can affect brain development in children, cause birth defects, and produce a variety of neurological, cardiac, and other damaging effects. In the United States alone, an estimated 10 million households still get drinking water delivered through lead pipes.

“It’s an unaddressed public health crisis that leads to over 1 million deaths annually,” says Jia Xu Brian Sia, an MIT postdoc and the senior author of the paper describing the new technology.

But testing for lead in water requires expensive, cumbersome equipment and typically requires days to get results. Or, it uses simple test strips that simply reveal a yes-or-no answer about the presence of lead but no information about its concentration. Current EPA regulations require drinking water to contain no more that 15 parts per billion of lead, a concentration so low it is difficult to detect.

The new system, which could be ready for commercial deployment within two or three years, could detect lead concentrations as low as 1 part per billion, with high accuracy, using a simple chip-based detector housed in a handheld device. The technology gives nearly instant quantitative measurements and requires just a droplet of water.

The findings are described in a paper appearing today in the journal Nature Communications, by Sia, MIT graduate student and lead author Luigi Ranno, Professor Juejun Hu, and 12 others at MIT and other institutions in academia and industry.

The team set out to find a simple detection method based on the use of photonic chips, which use light to perform measurements. The challenging part was finding a way to attach to the photonic chip surface certain ring-shaped molecules known as crown ethers, which can capture specific ions such as lead. After years of effort, they were able to achieve that attachment via a chemical process known as Fischer esterification. “That is one of the essential breakthroughs we have made in this technology,” Sia says.

In testing the new chip, the researchers showed that it can detect lead in water at concentrations as low as one part per billion. At much higher concentrations, which may be relevant for testing environmental contamination such as mine tailings, the accuracy is within 4 percent.

The device works in water with varying levels of acidity, ranging from pH values of 6 to 8, “which covers most environmental samples,” Sia says. They have tested the device with seawater as well as tap water, and verified the accuracy of the measurements.

In order to achieve such levels of accuracy, current testing requires a device called an inductive coupled plasma mass spectrometer. “These setups can be big and expensive,” Sia says. The sample processing can take days and requires experienced technical personnel.

While the new chip system they developed is “the core part of the innovation,” Ranno says, further work will be needed to develop this into an integrated, handheld device for practical use. “For making an actual product, you would need to package it into a usable form factor,” he explains. This would involve having a small chip-based laser coupled to the photonic chip. “It’s a matter of mechanical design, some optical design, some chemistry, and figuring out the supply chain,” he says. While that takes time, he says, the underlying concepts are straightforward.

The system can be adapted to detect other similar contaminants in water, including cadmium, copper, lithium, barium, cesium, and radium, Ranno says. The device could be used with simple cartridges that can be swapped out to detect different elements, each using slightly different crown ethers that can bind to a specific ion.

“There’s this problem that people don’t measure their water enough, especially in the developing countries,” Ranno says. “And that’s because they need to collect the water, prepare the sample, and bring it to these huge instruments that are extremely expensive.” Instead, “having this handheld device, something compact that even untrained personnel can just bring to the source for on-site monitoring, at low costs,” could make regular, ongoing widespread testing feasible.

Hu, who is the John F. Elliott Professor of Materials Science and Engineering, says, “I’m hoping this will be quickly implemented, so we can benefit human society. This is a good example of a technology coming from a lab innovation where it may actually make a very tangible impact on society, which is of course very fulfilling.”

“If this study can be extended to simultaneous detection of multiple metal elements, especially the presently concerning radioactive elements, its potential would be immense,” says Hou Wang, an associate professor of environmental science and engineering at Hunan University in China, who was not associated with this work.

Wang adds, “This research has engineered a sensor capable of instantaneously detecting lead concentration in water. This can be utilized in real-time to monitor the lead pollution concentration in wastewater discharged from industries such as battery manufacturing and lead smelting, facilitating the establishment of industrial wastewater monitoring systems. I think the innovative aspects and developmental potential of this research are quite commendable.”

Wang Qian, a principal research scientist at A*STAR’s Institute of Materials Research in Singapore, who also was not affiliated with this work, says, “The ability for the pervasive, portable, and quantitative detection of lead has proved to be challenging primarily due to cost concerns. This work demonstrates the potential to do so in a highly integrated form factor and is compatible with large-scale, low-cost manufacturing.”

The team included researchers at MIT, at Nanyang Technological University and Temasek Laboratories in Singapore, at the University of Southampton in the U.K., and at companies Fingate Technologies, in Singapore, and Vulcan Photonics, headquartered in Malaysia. The work used facilities at MIT.nano, the Harvard University Center for Nanoscale Systems, NTU’s Center for Micro- and Nano-Electronics, and the Nanyang Nanofabrication Center.

Engineers at MIT, Nanyang Technological University, and several companies have developed a compact and inexpensive technology for detecting and measuring lead concentrations in water, potentially enabling a significant advance in tackling this persistent global health issue.

The World Health Organization estimates that 240 million people worldwide are exposed to drinking water that contains unsafe amounts of toxic lead, which can affect brain development in children, cause birth defects, and produce a variety of neurological, cardiac, and other damaging effects. In the United States alone, an estimated 10 million households still get drinking water delivered through lead pipes.

“It’s an unaddressed public health crisis that leads to over 1 million deaths annually,” says Jia Xu Brian Sia, an MIT postdoc and the senior author of the paper describing the new technology.

But testing for lead in water requires expensive, cumbersome equipment and typically requires days to get results. Or, it uses simple test strips that simply reveal a yes-or-no answer about the presence of lead but no information about its concentration. Current EPA regulations require drinking water to contain no more that 15 parts per billion of lead, a concentration so low it is difficult to detect.

The new system, which could be ready for commercial deployment within two or three years, could detect lead concentrations as low as 1 part per billion, with high accuracy, using a simple chip-based detector housed in a handheld device. The technology gives nearly instant quantitative measurements and requires just a droplet of water.

The findings are described in a paper appearing today in the journal Nature Communications, by Sia, MIT graduate student and lead author Luigi Ranno, Professor Juejun Hu, and 12 others at MIT and other institutions in academia and industry.

The team set out to find a simple detection method based on the use of photonic chips, which use light to perform measurements. The challenging part was finding a way to attach to the photonic chip surface certain ring-shaped molecules known as crown ethers, which can capture specific ions such as lead. After years of effort, they were able to achieve that attachment via a chemical process known as Fischer esterification. “That is one of the essential breakthroughs we have made in this technology,” Sia says.

In testing the new chip, the researchers showed that it can detect lead in water at concentrations as low as one part per billion. At much higher concentrations, which may be relevant for testing environmental contamination such as mine tailings, the accuracy is within 4 percent.

The device works in water with varying levels of acidity, ranging from pH values of 6 to 8, “which covers most environmental samples,” Sia says. They have tested the device with seawater as well as tap water, and verified the accuracy of the measurements.

In order to achieve such levels of accuracy, current testing requires a device called an inductive coupled plasma mass spectrometer. “These setups can be big and expensive,” Sia says. The sample processing can take days and requires experienced technical personnel.

While the new chip system they developed is “the core part of the innovation,” Ranno says, further work will be needed to develop this into an integrated, handheld device for practical use. “For making an actual product, you would need to package it into a usable form factor,” he explains. This would involve having a small chip-based laser coupled to the photonic chip. “It’s a matter of mechanical design, some optical design, some chemistry, and figuring out the supply chain,” he says. While that takes time, he says, the underlying concepts are straightforward.

The system can be adapted to detect other similar contaminants in water, including cadmium, copper, lithium, barium, cesium, and radium, Ranno says. The device could be used with simple cartridges that can be swapped out to detect different elements, each using slightly different crown ethers that can bind to a specific ion.

“There’s this problem that people don’t measure their water enough, especially in the developing countries,” Ranno says. “And that’s because they need to collect the water, prepare the sample, and bring it to these huge instruments that are extremely expensive.” Instead, “having this handheld device, something compact that even untrained personnel can just bring to the source for on-site monitoring, at low costs,” could make regular, ongoing widespread testing feasible.

Hu, who is the John F. Elliott Professor of Materials Science and Engineering, says, “I’m hoping this will be quickly implemented, so we can benefit human society. This is a good example of a technology coming from a lab innovation where it may actually make a very tangible impact on society, which is of course very fulfilling.”

“If this study can be extended to simultaneous detection of multiple metal elements, especially the presently concerning radioactive elements, its potential would be immense,” says Hou Wang, an associate professor of environmental science and engineering at Hunan University in China, who was not associated with this work.

Wang adds, “This research has engineered a sensor capable of instantaneously detecting lead concentration in water. This can be utilized in real-time to monitor the lead pollution concentration in wastewater discharged from industries such as battery manufacturing and lead smelting, facilitating the establishment of industrial wastewater monitoring systems. I think the innovative aspects and developmental potential of this research are quite commendable.”

Wang Qian, a principal research scientist at A*STAR’s Institute of Materials Research in Singapore, who also was not affiliated with this work, says, “The ability for the pervasive, portable, and quantitative detection of lead has proved to be challenging primarily due to cost concerns. This work demonstrates the potential to do so in a highly integrated form factor and is compatible with large-scale, low-cost manufacturing.”

The team included researchers at MIT, at Nanyang Technological University and Temasek Laboratories in Singapore, at the University of Southampton in the U.K., and at companies Fingate Technologies, in Singapore, and Vulcan Photonics, headquartered in Malaysia. The work used facilities at MIT.nano, the Harvard University Center for Nanoscale Systems, NTU’s Center for Micro- and Nano-Electronics, and the Nanyang Nanofabrication Center.

The new plan to keep kids from drinking alcohol: Ban kids (and some adults) from buying drinks containing zero alcohol.

No, it doesn't make much sense.

But that's the argument being made by Molly A. Bowdring, a clinical psychologist at Stanford, who wrote this week in STAT that nonalcoholic drinks meant to resemble beer or cocktails are "a potential public health crisis."

The zero-proof beverage market includes brands like Athletic Brewing, by far the largest nonalcoholic beer brand, as well as a growing number of wine and spirits varieties. While nonalcoholic drinks still account for a tiny sliver of the overall beverage market, the rate of growth in recent years has been impressive—driven by consumers who are looking to enjoy a drink without getting drunk.

But won't someone think of the children, frets Bowdring. "While it's great that more people are taking to heart public health messages that reducing alcohol consumption can improve well-being and extend life, an important lesson from vaping as a replacement for cigarettes is being overlooked: What may be good for adults may be harmful to kids."

After contacting alcohol regulators in every U.S. state, she writes that she was shocked to find drinks that contain no alcohol are generally not subjected to limitations placed on drinks that do contain alcohol. Imagine that.

"Children and teens are, by and large, legally permitted to purchase non-alcoholic beverages. This is a huge liability," warns Bowdring. "The path from non-alcoholic beverage consumption to alcohol use among youths appears to be fairly direct….Among minors, consuming non-alcoholic beverages can socialize them to the drinking culture, with the beverages being perceived as cool, adult, and modern."

Goodness gracious, not that.

The logic here is seriously flawed in several ways. Most importantly, banning the sale of nonalcoholic drinks to individuals under 21—which includes a lot of adults, by the way—isn't going to make "drinking culture" seem much different. And even if it did, it is absolutely not the government's job to police what subcultures seem cool or interesting.

If there's a compelling reason for the state to prohibit the sale of alcohol to some individuals, it's on the grounds that consuming alcohol can increase the risk that they harm themselves or others. But kids are already prevented from legally purchasing or consuming alcohol—and someone who is purchasing or consuming a nonalcoholic drink is, by definition, not consuming alcohol in the first place!

Finally, Bowdring isn't arguing that kids who buy nonalcoholic drinks go on to become raging alcoholics or drunk drivers or anything dangerous like that. She's panicked over the possibility that they'll have an increased interest in drinking, period. But learning to drink socially and responsibly—which might include the consumption of nonalcoholic drinks at times—is a key part of being an adult.

This isn't an argument for banning video games because some kids who play video games will someday commit a school shooting. This is arguing for banning video games because some kids who play video games might someday drive a few miles per hour over the posted speed limit.

The post Will Banning Nonalcoholic Beer Save the Children? appeared first on Reason.com.

Engineers at MIT, Nanyang Technological University, and several companies have developed a compact and inexpensive technology for detecting and measuring lead concentrations in water, potentially enabling a significant advance in tackling this persistent global health issue.

The World Health Organization estimates that 240 million people worldwide are exposed to drinking water that contains unsafe amounts of toxic lead, which can affect brain development in children, cause birth defects, and produce a variety of neurological, cardiac, and other damaging effects. In the United States alone, an estimated 10 million households still get drinking water delivered through lead pipes.

“It’s an unaddressed public health crisis that leads to over 1 million deaths annually,” says Jia Xu Brian Sia, an MIT postdoc and the senior author of the paper describing the new technology.

But testing for lead in water requires expensive, cumbersome equipment and typically requires days to get results. Or, it uses simple test strips that simply reveal a yes-or-no answer about the presence of lead but no information about its concentration. Current EPA regulations require drinking water to contain no more that 15 parts per billion of lead, a concentration so low it is difficult to detect.

The new system, which could be ready for commercial deployment within two or three years, could detect lead concentrations as low as 1 part per billion, with high accuracy, using a simple chip-based detector housed in a handheld device. The technology gives nearly instant quantitative measurements and requires just a droplet of water.

The findings are described in a paper appearing today in the journal Nature Communications, by Sia, MIT graduate student and lead author Luigi Ranno, Professor Juejun Hu, and 12 others at MIT and other institutions in academia and industry.

The team set out to find a simple detection method based on the use of photonic chips, which use light to perform measurements. The challenging part was finding a way to attach to the photonic chip surface certain ring-shaped molecules known as crown ethers, which can capture specific ions such as lead. After years of effort, they were able to achieve that attachment via a chemical process known as Fischer esterification. “That is one of the essential breakthroughs we have made in this technology,” Sia says.

In testing the new chip, the researchers showed that it can detect lead in water at concentrations as low as one part per billion. At much higher concentrations, which may be relevant for testing environmental contamination such as mine tailings, the accuracy is within 4 percent.

The device works in water with varying levels of acidity, ranging from pH values of 6 to 8, “which covers most environmental samples,” Sia says. They have tested the device with seawater as well as tap water, and verified the accuracy of the measurements.

In order to achieve such levels of accuracy, current testing requires a device called an inductive coupled plasma mass spectrometer. “These setups can be big and expensive,” Sia says. The sample processing can take days and requires experienced technical personnel.

While the new chip system they developed is “the core part of the innovation,” Ranno says, further work will be needed to develop this into an integrated, handheld device for practical use. “For making an actual product, you would need to package it into a usable form factor,” he explains. This would involve having a small chip-based laser coupled to the photonic chip. “It’s a matter of mechanical design, some optical design, some chemistry, and figuring out the supply chain,” he says. While that takes time, he says, the underlying concepts are straightforward.

The system can be adapted to detect other similar contaminants in water, including cadmium, copper, lithium, barium, cesium, and radium, Ranno says. The device could be used with simple cartridges that can be swapped out to detect different elements, each using slightly different crown ethers that can bind to a specific ion.

“There’s this problem that people don’t measure their water enough, especially in the developing countries,” Ranno says. “And that’s because they need to collect the water, prepare the sample, and bring it to these huge instruments that are extremely expensive.” Instead, “having this handheld device, something compact that even untrained personnel can just bring to the source for on-site monitoring, at low costs,” could make regular, ongoing widespread testing feasible.

Hu, who is the John F. Elliott Professor of Materials Science and Engineering, says, “I’m hoping this will be quickly implemented, so we can benefit human society. This is a good example of a technology coming from a lab innovation where it may actually make a very tangible impact on society, which is of course very fulfilling.”

“If this study can be extended to simultaneous detection of multiple metal elements, especially the presently concerning radioactive elements, its potential would be immense,” says Hou Wang, an associate professor of environmental science and engineering at Hunan University in China, who was not associated with this work.

Wang adds, “This research has engineered a sensor capable of instantaneously detecting lead concentration in water. This can be utilized in real-time to monitor the lead pollution concentration in wastewater discharged from industries such as battery manufacturing and lead smelting, facilitating the establishment of industrial wastewater monitoring systems. I think the innovative aspects and developmental potential of this research are quite commendable.”

Wang Qian, a principal research scientist at A*STAR’s Institute of Materials Research in Singapore, who also was not affiliated with this work, says, “The ability for the pervasive, portable, and quantitative detection of lead has proved to be challenging primarily due to cost concerns. This work demonstrates the potential to do so in a highly integrated form factor and is compatible with large-scale, low-cost manufacturing.”

The team included researchers at MIT, at Nanyang Technological University and Temasek Laboratories in Singapore, at the University of Southampton in the U.K., and at companies Fingate Technologies, in Singapore, and Vulcan Photonics, headquartered in Malaysia. The work used facilities at MIT.nano, the Harvard University Center for Nanoscale Systems, NTU’s Center for Micro- and Nano-Electronics, and the Nanyang Nanofabrication Center.

Engineers at MIT, Nanyang Technological University, and several companies have developed a compact and inexpensive technology for detecting and measuring lead concentrations in water, potentially enabling a significant advance in tackling this persistent global health issue.

The World Health Organization estimates that 240 million people worldwide are exposed to drinking water that contains unsafe amounts of toxic lead, which can affect brain development in children, cause birth defects, and produce a variety of neurological, cardiac, and other damaging effects. In the United States alone, an estimated 10 million households still get drinking water delivered through lead pipes.

“It’s an unaddressed public health crisis that leads to over 1 million deaths annually,” says Jia Xu Brian Sia, an MIT postdoc and the senior author of the paper describing the new technology.

But testing for lead in water requires expensive, cumbersome equipment and typically requires days to get results. Or, it uses simple test strips that simply reveal a yes-or-no answer about the presence of lead but no information about its concentration. Current EPA regulations require drinking water to contain no more that 15 parts per billion of lead, a concentration so low it is difficult to detect.

The new system, which could be ready for commercial deployment within two or three years, could detect lead concentrations as low as 1 part per billion, with high accuracy, using a simple chip-based detector housed in a handheld device. The technology gives nearly instant quantitative measurements and requires just a droplet of water.

The findings are described in a paper appearing today in the journal Nature Communications, by Sia, MIT graduate student and lead author Luigi Ranno, Professor Juejun Hu, and 12 others at MIT and other institutions in academia and industry.

The team set out to find a simple detection method based on the use of photonic chips, which use light to perform measurements. The challenging part was finding a way to attach to the photonic chip surface certain ring-shaped molecules known as crown ethers, which can capture specific ions such as lead. After years of effort, they were able to achieve that attachment via a chemical process known as Fischer esterification. “That is one of the essential breakthroughs we have made in this technology,” Sia says.

In testing the new chip, the researchers showed that it can detect lead in water at concentrations as low as one part per billion. At much higher concentrations, which may be relevant for testing environmental contamination such as mine tailings, the accuracy is within 4 percent.

The device works in water with varying levels of acidity, ranging from pH values of 6 to 8, “which covers most environmental samples,” Sia says. They have tested the device with seawater as well as tap water, and verified the accuracy of the measurements.

In order to achieve such levels of accuracy, current testing requires a device called an inductive coupled plasma mass spectrometer. “These setups can be big and expensive,” Sia says. The sample processing can take days and requires experienced technical personnel.

While the new chip system they developed is “the core part of the innovation,” Ranno says, further work will be needed to develop this into an integrated, handheld device for practical use. “For making an actual product, you would need to package it into a usable form factor,” he explains. This would involve having a small chip-based laser coupled to the photonic chip. “It’s a matter of mechanical design, some optical design, some chemistry, and figuring out the supply chain,” he says. While that takes time, he says, the underlying concepts are straightforward.

The system can be adapted to detect other similar contaminants in water, including cadmium, copper, lithium, barium, cesium, and radium, Ranno says. The device could be used with simple cartridges that can be swapped out to detect different elements, each using slightly different crown ethers that can bind to a specific ion.

“There’s this problem that people don’t measure their water enough, especially in the developing countries,” Ranno says. “And that’s because they need to collect the water, prepare the sample, and bring it to these huge instruments that are extremely expensive.” Instead, “having this handheld device, something compact that even untrained personnel can just bring to the source for on-site monitoring, at low costs,” could make regular, ongoing widespread testing feasible.

Hu, who is the John F. Elliott Professor of Materials Science and Engineering, says, “I’m hoping this will be quickly implemented, so we can benefit human society. This is a good example of a technology coming from a lab innovation where it may actually make a very tangible impact on society, which is of course very fulfilling.”

“If this study can be extended to simultaneous detection of multiple metal elements, especially the presently concerning radioactive elements, its potential would be immense,” says Hou Wang, an associate professor of environmental science and engineering at Hunan University in China, who was not associated with this work.

Wang adds, “This research has engineered a sensor capable of instantaneously detecting lead concentration in water. This can be utilized in real-time to monitor the lead pollution concentration in wastewater discharged from industries such as battery manufacturing and lead smelting, facilitating the establishment of industrial wastewater monitoring systems. I think the innovative aspects and developmental potential of this research are quite commendable.”

Wang Qian, a principal research scientist at A*STAR’s Institute of Materials Research in Singapore, who also was not affiliated with this work, says, “The ability for the pervasive, portable, and quantitative detection of lead has proved to be challenging primarily due to cost concerns. This work demonstrates the potential to do so in a highly integrated form factor and is compatible with large-scale, low-cost manufacturing.”

The team included researchers at MIT, at Nanyang Technological University and Temasek Laboratories in Singapore, at the University of Southampton in the U.K., and at companies Fingate Technologies, in Singapore, and Vulcan Photonics, headquartered in Malaysia. The work used facilities at MIT.nano, the Harvard University Center for Nanoscale Systems, NTU’s Center for Micro- and Nano-Electronics, and the Nanyang Nanofabrication Center.

In a recent essay in the journal Monash Bioethics Review, oncologist Vinay Prasad and health researcher Alyson Haslam provide a comprehensive after-the-fact assessment of the federal government's rollout of the COVID-19 vaccines.

Their basic takeaway is that the vaccines were a "scientific success" tarnished by flawed federal vaccine policy.

The two argue the tremendous benefits of the COVID-19 vaccines for the elderly were undercut by government guidance and messaging that pushed vaccines on the young, healthy, and previously infected when data suggested that wasn't worthwhile (and was in some cases counterproductive).

Worse still, the government even pushed vaccine mandates when it was increasingly clear the vaccines did not stop COVID-19 transmission, they argue.

To correct these errors for future pandemic responses, Prasad and Haslam recommend performing larger vaccine trials and collecting better data on vaccine performance in lower-risk populations. They also urge policy makers to be more willing to acknowledge the tradeoffs of vaccination.

That's sound advice. We'll have to wait and see if the government adopts it come the next pandemic.

There is one policy that they don't mention and doesn't totally depend on the government getting better at judging the risks of new vaccines: Charge people for them.

Had the government not provided COVID-19 vaccines for free and shielded vaccine makers and administrators from any liability for adverse reactions, prices could have better rationed vaccine supply and better informed people about their risks and benefits.

Without prices, people were instead left with flawed government recommendations, incentives, and rationing schemes.

Those who recall early 2021 will remember the complex, often transparently silly eligibility criteria state governments set up to ration scarce vaccine supplies. This often involved prioritizing younger, healthier, often politically connected "essential workers" over elderly people.

Prasad and Haslam criticize this as a government failure to prioritize groups at most risk of dying from COVID-19.

"While the UK prioritized nursing home residents and older individuals…the US included essential workers, including young, resident physicians," write Prasad and Haslam. "Health care workers face higher risks of acquiring the virus due to occupation (though this was and is offset by available personal protective equipment), but this was less than the elevated risk of death faced by older individuals."

Yet if the government hadn't assigned itself the role of distributing vaccines for free, it wouldn't have been forced into this position of rationing scarce vaccine supplies.

Demand for the vaccine is a function of the vaccine's price. Since the vaccine's price was $0, people who stood to gain comparatively less from vaccination and people for whom a vaccine would be lifesaving were equally incentivized to receive it.

Consequently, everyone rushed to get in line at the same time. The government then had to decide who got it first and predictably made flawed decisions.

Had vaccine makers been left to sell their product on an open market (instead of selling doses in bulk to the federal government to distribute for free), the elderly and those most at risk of COVID-19 would have been able to outbid people who could afford to wait longer. Perhaps more lives could have been saved.

Over the course of 2021, the supply of vaccines outgrew demand.

At the same time, as Prasad and Haslam recount, an increasing number of people (particularly young men) were developing myocarditis as a result of vaccination. Nevertheless, the government downplayed this risk, continued to urge younger populations to get vaccinated, and failed to collect data about the potential risks of vaccination.

That's all a failure of the government policy. Even if the government was slow to adjust its recommendations, prices could have played a constructive role in informing people about their own risk-reward tradeoff of getting vaccinated.

If a 20-year-old man who'd already had COVID-19 had to spend something to get vaccinated, instead of nothing, fewer would have. Prasad and Haslam argue that would have been the right call healthwise.

Without prices, that hypothetical 20-year-old's decision was informed mostly by government guidance, and, later, government mandates.

The government compounded this lack of prices by giving liability shields to vaccine makers. As it stands right now, no one is able to sue the maker of a COVID-19 vaccine should they have an adverse reaction. (Unlike standard, non-COVID vaccines, people are also not allowed to sue the government for compensation for the vaccine injuries.)

If pharmaceutical companies had to charge individual consumers to make money off their vaccines, and if those prices had to reflect the liability risks of the side effects some number of people would inevitably have, consumers would have been even better informed about the risks and rewards of vaccination.

One might counter that individual consumers aren't in a position to perform this risk-reward calculation on their own.

That ignores the ways that other intermediaries in a better position to evaluate the costs and benefits of vaccination could contribute to the price signals individuals would use to make their own decisions.

One could imagine an insurance company declining to cover COVID-19 vaccines for the aforementioned healthy 20-year-old while subsidizing their elderly customers to get the shot. (This is, of course, illegal right now. The Affordable Care Act requires most insurance plans to cover the costs of vaccination for everyone.)

Instead, the financial incentives that were attached to vaccination were another part of the federally subsidized vaccination campaign.

State Medicaid programs paid providers bonuses for the number of patients they vaccinated (regardless of how at risk of COVID-19 those patients were). State governments gave out gift cards to those who got vaccinated and entered them in lotteries to win even bigger prizes.

Leaving it up to private companies to produce and charge for vaccines would have one added benefit: It would make it much more difficult for the government to mandate vaccines or otherwise coerce people into getting them.

One of the things that made it easy for local and state governments to bar the unvaccinated from restaurants and schools was that they also had a lot of free, federally subsidized doses to give away. People didn't have a real "excuse" not to get a shot.

Had people been required to pay for vaccines, it would have been more awkward and much harder (politically and practically) to mandate that they do so.

Economist Alex Tabarrok likes to say that a "price is a signal wrapped up in an incentive." They signal crucial information and then incentivize people to act on that information in a rational, efficient way.

By divorcing COVID-19 vaccines from real price signals, we were left with an earnest, government-led vaccination effort. That effort got a lot of lifesaving vaccines to a lot of people.

But it also encouraged and subsidized people to get vaccinated when it was probably not a necessary or even good idea. When not enough people got vaccinated, governments turned to coercive mandates.

The post The COVID-19 Vaccines Shouldn't Have Been Free appeared first on Reason.com.

Engineers at MIT, Nanyang Technological University, and several companies have developed a compact and inexpensive technology for detecting and measuring lead concentrations in water, potentially enabling a significant advance in tackling this persistent global health issue.

The World Health Organization estimates that 240 million people worldwide are exposed to drinking water that contains unsafe amounts of toxic lead, which can affect brain development in children, cause birth defects, and produce a variety of neurological, cardiac, and other damaging effects. In the United States alone, an estimated 10 million households still get drinking water delivered through lead pipes.

“It’s an unaddressed public health crisis that leads to over 1 million deaths annually,” says Jia Xu Brian Sia, an MIT postdoc and the senior author of the paper describing the new technology.

But testing for lead in water requires expensive, cumbersome equipment and typically requires days to get results. Or, it uses simple test strips that simply reveal a yes-or-no answer about the presence of lead but no information about its concentration. Current EPA regulations require drinking water to contain no more that 15 parts per billion of lead, a concentration so low it is difficult to detect.

The new system, which could be ready for commercial deployment within two or three years, could detect lead concentrations as low as 1 part per billion, with high accuracy, using a simple chip-based detector housed in a handheld device. The technology gives nearly instant quantitative measurements and requires just a droplet of water.

The findings are described in a paper appearing today in the journal Nature Communications, by Sia, MIT graduate student and lead author Luigi Ranno, Professor Juejun Hu, and 12 others at MIT and other institutions in academia and industry.

The team set out to find a simple detection method based on the use of photonic chips, which use light to perform measurements. The challenging part was finding a way to attach to the photonic chip surface certain ring-shaped molecules known as crown ethers, which can capture specific ions such as lead. After years of effort, they were able to achieve that attachment via a chemical process known as Fischer esterification. “That is one of the essential breakthroughs we have made in this technology,” Sia says.

In testing the new chip, the researchers showed that it can detect lead in water at concentrations as low as one part per billion. At much higher concentrations, which may be relevant for testing environmental contamination such as mine tailings, the accuracy is within 4 percent.

The device works in water with varying levels of acidity, ranging from pH values of 6 to 8, “which covers most environmental samples,” Sia says. They have tested the device with seawater as well as tap water, and verified the accuracy of the measurements.

In order to achieve such levels of accuracy, current testing requires a device called an inductive coupled plasma mass spectrometer. “These setups can be big and expensive,” Sia says. The sample processing can take days and requires experienced technical personnel.

While the new chip system they developed is “the core part of the innovation,” Ranno says, further work will be needed to develop this into an integrated, handheld device for practical use. “For making an actual product, you would need to package it into a usable form factor,” he explains. This would involve having a small chip-based laser coupled to the photonic chip. “It’s a matter of mechanical design, some optical design, some chemistry, and figuring out the supply chain,” he says. While that takes time, he says, the underlying concepts are straightforward.

The system can be adapted to detect other similar contaminants in water, including cadmium, copper, lithium, barium, cesium, and radium, Ranno says. The device could be used with simple cartridges that can be swapped out to detect different elements, each using slightly different crown ethers that can bind to a specific ion.

“There’s this problem that people don’t measure their water enough, especially in the developing countries,” Ranno says. “And that’s because they need to collect the water, prepare the sample, and bring it to these huge instruments that are extremely expensive.” Instead, “having this handheld device, something compact that even untrained personnel can just bring to the source for on-site monitoring, at low costs,” could make regular, ongoing widespread testing feasible.

Hu, who is the John F. Elliott Professor of Materials Science and Engineering, says, “I’m hoping this will be quickly implemented, so we can benefit human society. This is a good example of a technology coming from a lab innovation where it may actually make a very tangible impact on society, which is of course very fulfilling.”

“If this study can be extended to simultaneous detection of multiple metal elements, especially the presently concerning radioactive elements, its potential would be immense,” says Hou Wang, an associate professor of environmental science and engineering at Hunan University in China, who was not associated with this work.

Wang adds, “This research has engineered a sensor capable of instantaneously detecting lead concentration in water. This can be utilized in real-time to monitor the lead pollution concentration in wastewater discharged from industries such as battery manufacturing and lead smelting, facilitating the establishment of industrial wastewater monitoring systems. I think the innovative aspects and developmental potential of this research are quite commendable.”

Wang Qian, a principal research scientist at the Institute of Materials Research in Singapore, who also was not affiliated with this work, says, “The ability for the pervasive, portable, and quantitative detection of lead has proved to be challenging primarily due to cost concerns. This work demonstrates the potential to do so in a highly integrated form factor and is compatible with large-scale, low-cost manufacturing.”

The team included researchers at MIT, at Nanyang Technological University and Temasek Laboratories in Singapore, at the University of Southampton in the U.K., and at companies Fingate Technologies, in Singapore, and Vulcan Photonics, headquartered in Malaysia. The work used facilities at MIT.nano, the Harvard University Center for Nanoscale Systems, NTU’s Center for Micro- and Nano-Electronics, and the Nanyang Nanofabrication Center.

RNA vaccines against Covid-19 have proven effective at reducing the severity of disease. However, a team of researchers at MIT is working on making them even better. By tweaking the design of the vaccines, the researchers showed that they could generate Covid-19 RNA vaccines that produce a stronger immune response, at a lower dose, in mice.

Adjuvants are molecules commonly used to increase the immune response to vaccines, but they haven’t yet been used in RNA vaccines.  In this study, the MIT researchers engineered both the nanoparticles used to deliver the Covid-19 antigen, and the antigen itself, to boost the immune response, without the need for a separate adjuvant.

If further developed for use in humans, this type of RNA vaccine could help to reduce costs, reduce the dosage needed, and potentially lead to longer-lasting immunity. The researchers’ tests also showed that when delivered intranasally, the vaccine induced a strong immune response when compared to the response elicited by traditional, intramuscular vaccination.

“With intranasal vaccination, you might be able to kill Covid at the mucus membrane, before it gets into your body,” says Daniel Anderson, a professor in MIT’s Department of Chemical Engineering, a member of MIT’s Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science (IMES), and the senior author of the study. “Intranasal vaccines may also be easier to administer to many people, since they don’t require an injection.”

The researchers believe that the effectiveness of other types of RNA vaccines that are now in development, including vaccines for cancer, could be improved by incorporating similar immune-stimulating properties.

Former MIT postdoc Bowen Li, who is now an assistant professor at the University of Toronto; graduate student Allen Jiang; and former MIT postdoc Idris Raji, who was a research fellow at Boston Children’s Hospital, are the lead authors of the new study, which appears today in Nature Biomedical Engineering. The research team also includes Robert Langer, the David H. Koch Institute Professor at MIT and a member of the Koch Institute, and several other MIT researchers.

Boosting immunity

RNA vaccines consist of a strand of RNA that encodes a viral or bacterial protein, also called an antigen. In the case of Covid-19 vaccines, this RNA codes for a segment of the virus’s spike protein. That RNA strand is packaged in a lipid nanoparticle carrier, which protects the RNA from being broken down in the body and helps it get into cells.

Once delivered into cells, the RNA is translated into proteins that the immune system can detect, generating antibodies and T cells that will recognize the protein if the person later becomes infected with the SARS-CoV-2 virus.

The original Covid-19 RNA vaccines developed by Moderna and Pfizer/BioNTech provoked strong immune responses, but the MIT team wanted to see if they could make them more effective by engineering them to have immune stimulatory properties.

In this study, the researchers employed two different strategies to boost the immune response. For the first, they focused on a protein called C3d, which is part of an arm of the immune response known as the complement system. This set of proteins helps the body fight off infection, and C3d’s role is to bind to antigens and amplify the antibody response to those antigens. For many years, scientists have been evaluating the use of C3d as a molecular adjuvant for vaccines made from proteins, such as the DPT vaccine.  

“With the promise of mRNA technologies being realized with the Covid vaccines, we thought that this would be a fantastic opportunity to see if C3d might also be able to play a role as an adjuvant in mRNA vaccine systems,” Jiang says.

To that end, the researchers engineered the mRNA to encode the C3d protein fused to the antigen, so that both components are produced as one protein by cells that receive the vaccine.

In the second phase of their strategy, the researchers modified the lipid nanoparticles used to deliver the RNA vaccine, so that in addition to helping with RNA delivery, the lipids also intrinsically stimulate a stronger immune response.

To identify lipids that would work best, the researchers created a library of 480 lipid nanoparticles with different types of chemistries. All of these are “ionizable” lipids, which become positively charged when they enter acidic environments. The original Covid RNA vaccines also included some ionizable lipids because they help the nanoparticles to self-assemble with RNA and they help target cells to take up the vaccine.

“We understood that nanoparticles themselves could be immunostimulatory, but we weren't quite sure what the chemistry was that was needed to optimize that response. So instead of trying to make the perfect one, we made a library and evaluated them, and through that we identified some chemistries that seemed to improve their response,” Anderson says.

Toward intranasal vaccines

The researchers tested their new vaccine, which included both RNA-encoded C3d and a top-performing ionizable lipid identified from their library screen, in mice. They found that mice injected with this vaccine produced 10 times more antibodies than mice given unadjuvanted Covid RNA vaccines. The new vaccine also provoked a stronger response among T cells, which play important roles in combating the SARS-CoV-2 virus.

“For the first time, we’ve demonstrated a synergistic boost in immune responses by engineering both the RNA and its delivery vehicles,” Li says. “This prompted us to investigate the feasibility of administering this new RNA vaccine platform intranasally, considering the challenges presented by the mucociliary blanket barrier in the upper airways.”

When the researchers delivered the vaccine intranasally, they observed a similarly strong immune response in the mice. If developed for use in people, an intranasal vaccine could potentially offer enhanced protection against infection because it would generate an immune response within the mucosal tissues that line the nasal passages and lungs. 

Because self-adjuvanting vaccines elicit a stronger response at a lower dose, this approach could also help to reduce the cost of vaccine doses, which might allow them to reach more people, especially in developing nations, the researchers say.

Anderson’s lab is now exploring whether this self-adjuvanting platform might also help boost the immune response of other types of RNA vaccines, including cancer vaccines. Working with health care companies, the researchers also plan to test the effectiveness and safety of these new vaccine formulations in larger animal models, in hopes of eventually testing them in patients.

The research was funded by the National Institutes of Health and Translate Bio.

The Scottish Ambulance Service fired Christopher Gallacher, a duty manager at West Centre in Glasgow, after finding he had an on-duty emergency dispatcher pick him and his family up at the airport after a vacation. According to a disciplinary tribunal, this happened on an evening when there were a "high number of calls" and patients were waiting for "lengthy periods of time." The dispatcher was away from his post for 45 minutes. Gallacher said he had assumed the man would use his break to pick him up.

The post Brickbat: Free Ride appeared first on Reason.com.

RNA vaccines against Covid-19 have proven effective at reducing the severity of disease. However, a team of researchers at MIT is working on making them even better. By tweaking the design of the vaccines, the researchers showed that they could generate Covid-19 RNA vaccines that produce a stronger immune response, at a lower dose, in mice.

Adjuvants are molecules commonly used to increase the immune response to vaccines, but they haven’t yet been used in RNA vaccines.  In this study, the MIT researchers engineered both the nanoparticles used to deliver the Covid-19 antigen, and the antigen itself, to boost the immune response, without the need for a separate adjuvant.

If further developed for use in humans, this type of RNA vaccine could help to reduce costs, reduce the dosage needed, and potentially lead to longer-lasting immunity. The researchers’ tests also showed that when delivered intranasally, the vaccine induced a strong immune response when compared to the response elicited by traditional, intramuscular vaccination.

“With intranasal vaccination, you might be able to kill Covid at the mucus membrane, before it gets into your body,” says Daniel Anderson, a professor in MIT’s Department of Chemical Engineering, a member of MIT’s Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science (IMES), and the senior author of the study. “Intranasal vaccines may also be easier to administer to many people, since they don’t require an injection.”

The researchers believe that the effectiveness of other types of RNA vaccines that are now in development, including vaccines for cancer, could be improved by incorporating similar immune-stimulating properties.

Former MIT postdoc Bowen Li, who is now an assistant professor at the University of Toronto; graduate student Allen Jiang; and former MIT postdoc Idris Raji, who was a research fellow at Boston Children’s Hospital, are the lead authors of the new study, which appears today in Nature Biomedical Engineering. The research team also includes Robert Langer, the David H. Koch Institute Professor at MIT and a member of the Koch Institute, and several other MIT researchers.

Boosting immunity

RNA vaccines consist of a strand of RNA that encodes a viral or bacterial protein, also called an antigen. In the case of Covid-19 vaccines, this RNA codes for a segment of the virus’s spike protein. That RNA strand is packaged in a lipid nanoparticle carrier, which protects the RNA from being broken down in the body and helps it get into cells.

Once delivered into cells, the RNA is translated into proteins that the immune system can detect, generating antibodies and T cells that will recognize the protein if the person later becomes infected with the SARS-CoV-2 virus.

The original Covid-19 RNA vaccines developed by Moderna and Pfizer/BioNTech provoked strong immune responses, but the MIT team wanted to see if they could make them more effective by engineering them to have immune stimulatory properties.

In this study, the researchers employed two different strategies to boost the immune response. For the first, they focused on a protein called C3d, which is part of an arm of the immune response known as the complement system. This set of proteins helps the body fight off infection, and C3d’s role is to bind to antigens and amplify the antibody response to those antigens. For many years, scientists have been evaluating the use of C3d as a molecular adjuvant for vaccines made from proteins, such as the DPT vaccine.  

“With the promise of mRNA technologies being realized with the Covid vaccines, we thought that this would be a fantastic opportunity to see if C3d might also be able to play a role as an adjuvant in mRNA vaccine systems,” Jiang says.

To that end, the researchers engineered the mRNA to encode the C3d protein fused to the antigen, so that both components are produced as one protein by cells that receive the vaccine.

In the second phase of their strategy, the researchers modified the lipid nanoparticles used to deliver the RNA vaccine, so that in addition to helping with RNA delivery, the lipids also intrinsically stimulate a stronger immune response.

To identify lipids that would work best, the researchers created a library of 480 lipid nanoparticles with different types of chemistries. All of these are “ionizable” lipids, which become positively charged when they enter acidic environments. The original Covid RNA vaccines also included some ionizable lipids because they help the nanoparticles to self-assemble with RNA and they help target cells to take up the vaccine.

“We understood that nanoparticles themselves could be immunostimulatory, but we weren't quite sure what the chemistry was that was needed to optimize that response. So instead of trying to make the perfect one, we made a library and evaluated them, and through that we identified some chemistries that seemed to improve their response,” Anderson says.

Toward intranasal vaccines

The researchers tested their new vaccine, which included both RNA-encoded C3d and a top-performing ionizable lipid identified from their library screen, in mice. They found that mice injected with this vaccine produced 10 times more antibodies than mice given unadjuvanted Covid RNA vaccines. The new vaccine also provoked a stronger response among T cells, which play important roles in combating the SARS-CoV-2 virus.

“For the first time, we’ve demonstrated a synergistic boost in immune responses by engineering both the RNA and its delivery vehicles,” Li says. “This prompted us to investigate the feasibility of administering this new RNA vaccine platform intranasally, considering the challenges presented by the mucociliary blanket barrier in the upper airways.”

When the researchers delivered the vaccine intranasally, they observed a similarly strong immune response in the mice. If developed for use in people, an intranasal vaccine could potentially offer enhanced protection against infection because it would generate an immune response within the mucosal tissues that line the nasal passages and lungs. 

Because self-adjuvanting vaccines elicit a stronger response at a lower dose, this approach could also help to reduce the cost of vaccine doses, which might allow them to reach more people, especially in developing nations, the researchers say.

Anderson’s lab is now exploring whether this self-adjuvanting platform might also help boost the immune response of other types of RNA vaccines, including cancer vaccines. Working with health care companies, the researchers also plan to test the effectiveness and safety of these new vaccine formulations in larger animal models, in hopes of eventually testing them in patients.

The research was funded by the National Institutes of Health and Translate Bio.

RNA vaccines against Covid-19 have proven effective at reducing the severity of disease. However, a team of researchers at MIT is working on making them even better. By tweaking the design of the vaccines, the researchers showed that they could generate Covid-19 RNA vaccines that produce a stronger immune response, at a lower dose, in mice.

Adjuvants are molecules commonly used to increase the immune response to vaccines, but they haven’t yet been used in RNA vaccines.  In this study, the MIT researchers engineered both the nanoparticles used to deliver the Covid-19 antigen, and the antigen itself, to boost the immune response, without the need for a separate adjuvant.

If further developed for use in humans, this type of RNA vaccine could help to reduce costs, reduce the dosage needed, and potentially lead to longer-lasting immunity. The researchers’ tests also showed that when delivered intranasally, the vaccine induced a strong immune response when compared to the response elicited by traditional, intramuscular vaccination.

“With intranasal vaccination, you might be able to kill Covid at the mucus membrane, before it gets into your body,” says Daniel Anderson, a professor in MIT’s Department of Chemical Engineering, a member of MIT’s Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science (IMES), and the senior author of the study. “Intranasal vaccines may also be easier to administer to many people, since they don’t require an injection.”

The researchers believe that the effectiveness of other types of RNA vaccines that are now in development, including vaccines for cancer, could be improved by incorporating similar immune-stimulating properties.

Former MIT postdoc Bowen Li, who is now an assistant professor at the University of Toronto; graduate student Allen Jiang; and former MIT postdoc Idris Raji, who was a research fellow at Boston Children’s Hospital, are the lead authors of the new study, which appears today in Nature Biomedical Engineering. The research team also includes Robert Langer, the David H. Koch Institute Professor at MIT and a member of the Koch Institute, and several other MIT researchers.

Boosting immunity

RNA vaccines consist of a strand of RNA that encodes a viral or bacterial protein, also called an antigen. In the case of Covid-19 vaccines, this RNA codes for a segment of the virus’s spike protein. That RNA strand is packaged in a lipid nanoparticle carrier, which protects the RNA from being broken down in the body and helps it get into cells.

Once delivered into cells, the RNA is translated into proteins that the immune system can detect, generating antibodies and T cells that will recognize the protein if the person later becomes infected with the SARS-CoV-2 virus.

The original Covid-19 RNA vaccines developed by Moderna and Pfizer/BioNTech provoked strong immune responses, but the MIT team wanted to see if they could make them more effective by engineering them to have immune stimulatory properties.

In this study, the researchers employed two different strategies to boost the immune response. For the first, they focused on a protein called C3d, which is part of an arm of the immune response known as the complement system. This set of proteins helps the body fight off infection, and C3d’s role is to bind to antigens and amplify the antibody response to those antigens. For many years, scientists have been evaluating the use of C3d as a molecular adjuvant for vaccines made from proteins, such as the DPT vaccine.  

“With the promise of mRNA technologies being realized with the Covid vaccines, we thought that this would be a fantastic opportunity to see if C3d might also be able to play a role as an adjuvant in mRNA vaccine systems,” Jiang says.

To that end, the researchers engineered the mRNA to encode the C3d protein fused to the antigen, so that both components are produced as one protein by cells that receive the vaccine.

In the second phase of their strategy, the researchers modified the lipid nanoparticles used to deliver the RNA vaccine, so that in addition to helping with RNA delivery, the lipids also intrinsically stimulate a stronger immune response.

To identify lipids that would work best, the researchers created a library of 480 lipid nanoparticles with different types of chemistries. All of these are “ionizable” lipids, which become positively charged when they enter acidic environments. The original Covid RNA vaccines also included some ionizable lipids because they help the nanoparticles to self-assemble with RNA and they help target cells to take up the vaccine.

“We understood that nanoparticles themselves could be immunostimulatory, but we weren't quite sure what the chemistry was that was needed to optimize that response. So instead of trying to make the perfect one, we made a library and evaluated them, and through that we identified some chemistries that seemed to improve their response,” Anderson says.

Toward intranasal vaccines

The researchers tested their new vaccine, which included both RNA-encoded C3d and a top-performing ionizable lipid identified from their library screen, in mice. They found that mice injected with this vaccine produced 10 times more antibodies than mice given unadjuvanted Covid RNA vaccines. The new vaccine also provoked a stronger response among T cells, which play important roles in combating the SARS-CoV-2 virus.

“For the first time, we’ve demonstrated a synergistic boost in immune responses by engineering both the RNA and its delivery vehicles,” Li says. “This prompted us to investigate the feasibility of administering this new RNA vaccine platform intranasally, considering the challenges presented by the mucociliary blanket barrier in the upper airways.”

When the researchers delivered the vaccine intranasally, they observed a similarly strong immune response in the mice. If developed for use in people, an intranasal vaccine could potentially offer enhanced protection against infection because it would generate an immune response within the mucosal tissues that line the nasal passages and lungs. 

Because self-adjuvanting vaccines elicit a stronger response at a lower dose, this approach could also help to reduce the cost of vaccine doses, which might allow them to reach more people, especially in developing nations, the researchers say.

Anderson’s lab is now exploring whether this self-adjuvanting platform might also help boost the immune response of other types of RNA vaccines, including cancer vaccines. Working with health care companies, the researchers also plan to test the effectiveness and safety of these new vaccine formulations in larger animal models, in hopes of eventually testing them in patients.

The research was funded by the National Institutes of Health and Translate Bio.

United Airlines received its first Airbus A321neo airplanes in December, and it has already had to ground them. But United wants you to know there were no safety issues—rather, it has to do with a 1990 Federal Aviation Administration rule requiring "No Smoking" signs to be operated by the flight crew, even though smoking on airplanes has been banned for decades. The A321neo has software that keeps the "No Smoking" sign turned on continuously during flights. In 2020, United got an exemption to that rule for all of its planes that keep the sign on continuously. But that exemption only applies to the aircraft it listed at the time. United has since applied for an exemption for the Airbus A321neo, and it says the FAA has agreed to let the airline fly those aircraft while it evaluates the application.

The post Brickbat: Grounded Already appeared first on Reason.com.

RNA vaccines against Covid-19 have proven effective at reducing the severity of disease. However, a team of researchers at MIT is working on making them even better. By tweaking the design of the vaccines, the researchers showed that they could generate Covid-19 RNA vaccines that produce a stronger immune response, at a lower dose, in mice.

Adjuvants are molecules commonly used to increase the immune response to vaccines, but they haven’t yet been used in RNA vaccines.  In this study, the MIT researchers engineered both the nanoparticles used to deliver the Covid-19 antigen, and the antigen itself, to boost the immune response, without the need for a separate adjuvant.

If further developed for use in humans, this type of RNA vaccine could help to reduce costs, reduce the dosage needed, and potentially lead to longer-lasting immunity. The researchers’ tests also showed that when delivered intranasally, the vaccine induced a strong immune response when compared to the response elicited by traditional, intramuscular vaccination.

“With intranasal vaccination, you might be able to kill Covid at the mucus membrane, before it gets into your body,” says Daniel Anderson, a professor in MIT’s Department of Chemical Engineering, a member of MIT’s Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science (IMES), and the senior author of the study. “Intranasal vaccines may also be easier to administer to many people, since they don’t require an injection.”

The researchers believe that the effectiveness of other types of RNA vaccines that are now in development, including vaccines for cancer, could be improved by incorporating similar immune-stimulating properties.

Former MIT postdoc Bowen Li, who is now an assistant professor at the University of Toronto; graduate student Allen Jiang; and former MIT postdoc Idris Raji, who was a research fellow at Boston Children’s Hospital, are the lead authors of the new study, which appears today in Nature Biomedical Engineering. The research team also includes Robert Langer, the David H. Koch Institute Professor at MIT and a member of the Koch Institute, and several other MIT researchers.

Boosting immunity

RNA vaccines consist of a strand of RNA that encodes a viral or bacterial protein, also called an antigen. In the case of Covid-19 vaccines, this RNA codes for a segment of the virus’s spike protein. That RNA strand is packaged in a lipid nanoparticle carrier, which protects the RNA from being broken down in the body and helps it get into cells.

Once delivered into cells, the RNA is translated into proteins that the immune system can detect, generating antibodies and T cells that will recognize the protein if the person later becomes infected with the SARS-CoV-2 virus.

The original Covid-19 RNA vaccines developed by Moderna and Pfizer/BioNTech provoked strong immune responses, but the MIT team wanted to see if they could make them more effective by engineering them to have immune stimulatory properties.

In this study, the researchers employed two different strategies to boost the immune response. For the first, they focused on a protein called C3d, which is part of an arm of the immune response known as the complement system. This set of proteins helps the body fight off infection, and C3d’s role is to bind to antigens and amplify the antibody response to those antigens. For many years, scientists have been evaluating the use of C3d as a molecular adjuvant for vaccines made from proteins, such as the DPT vaccine.  

“With the promise of mRNA technologies being realized with the Covid vaccines, we thought that this would be a fantastic opportunity to see if C3d might also be able to play a role as an adjuvant in mRNA vaccine systems,” Jiang says.

To that end, the researchers engineered the mRNA to encode the C3d protein fused to the antigen, so that both components are produced as one protein by cells that receive the vaccine.

In the second phase of their strategy, the researchers modified the lipid nanoparticles used to deliver the RNA vaccine, so that in addition to helping with RNA delivery, the lipids also intrinsically stimulate a stronger immune response.

To identify lipids that would work best, the researchers created a library of 480 lipid nanoparticles with different types of chemistries. All of these are “ionizable” lipids, which become positively charged when they enter acidic environments. The original Covid RNA vaccines also included some ionizable lipids because they help the nanoparticles to self-assemble with RNA and they help target cells to take up the vaccine.

“We understood that nanoparticles themselves could be immunostimulatory, but we weren't quite sure what the chemistry was that was needed to optimize that response. So instead of trying to make the perfect one, we made a library and evaluated them, and through that we identified some chemistries that seemed to improve their response,” Anderson says.

Toward intranasal vaccines

The researchers tested their new vaccine, which included both RNA-encoded C3d and a top-performing ionizable lipid identified from their library screen, in mice. They found that mice injected with this vaccine produced 10 times more antibodies than mice given unadjuvanted Covid RNA vaccines. The new vaccine also provoked a stronger response among T cells, which play important roles in combating the SARS-CoV-2 virus.

“For the first time, we’ve demonstrated a synergistic boost in immune responses by engineering both the RNA and its delivery vehicles,” Li says. “This prompted us to investigate the feasibility of administering this new RNA vaccine platform intranasally, considering the challenges presented by the mucociliary blanket barrier in the upper airways.”

When the researchers delivered the vaccine intranasally, they observed a similarly strong immune response in the mice. If developed for use in people, an intranasal vaccine could potentially offer enhanced protection against infection because it would generate an immune response within the mucosal tissues that line the nasal passages and lungs. 

Because self-adjuvanting vaccines elicit a stronger response at a lower dose, this approach could also help to reduce the cost of vaccine doses, which might allow them to reach more people, especially in developing nations, the researchers say.

Anderson’s lab is now exploring whether this self-adjuvanting platform might also help boost the immune response of other types of RNA vaccines, including cancer vaccines. Working with health care companies, the researchers also plan to test the effectiveness and safety of these new vaccine formulations in larger animal models, in hopes of eventually testing them in patients.

The research was funded by the National Institutes of Health and Translate Bio.